Global and United States Terbinafine Hydrochloride Drug Market Insights, Forecast to 2026

Publication ID:

QYR11200967

Publication Date:

November 23, 2020

Pages:

148

Publisher:

QYR

Region:

Global [1]

$3,900.00

Description:

Terbinafine Hydrochloride Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Terbinafine Hydrochloride Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Terbinafine Hydrochloride Drug market is segmented into
Topical
Oral

Segment by Application, the Terbinafine Hydrochloride Drug market is segmented into
Fingernail Infection
Toenail Infection
Others

Regional and Country-level Analysis
The Terbinafine Hydrochloride Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Terbinafine Hydrochloride Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Terbinafine Hydrochloride Drug Market Share Analysis
Terbinafine Hydrochloride Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Terbinafine Hydrochloride Drug business, the date to enter into the Terbinafine Hydrochloride Drug market, Terbinafine Hydrochloride Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
GSK
TEVA
Dr. Reddy's Laboratories
CIPLA LTD
TARO
InvaGen Pharmaceuticals
Breckenridge Pharmaceutical
Harris Pharmaceutical
Glenmark
Orchid Healthcare
APOTEX
Jilin Wantong Group
Cussess
Hubei Hengan Fulin Pharm
Xiuzheng Pharmaceutical

Table Of Contents:

1 Study Coverage
1.1 Terbinafine Hydrochloride Drug Product Introduction
1.2 Market Segments
1.3 Key Terbinafine Hydrochloride Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Type
1.4.2 Topical
1.4.3 Oral
1.5 Market by Application
1.5.1 Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Application
1.5.2 Fingernail Infection
1.5.3 Toenail Infection
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Terbinafine Hydrochloride Drug Market Size, Estimates and Forecasts
2.1.1 Global Terbinafine Hydrochloride Drug Revenue 2015-2026
2.1.2 Global Terbinafine Hydrochloride Drug Sales 2015-2026
2.2 Global Terbinafine Hydrochloride Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Terbinafine Hydrochloride Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Terbinafine Hydrochloride Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Terbinafine Hydrochloride Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Terbinafine Hydrochloride Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Region (2021-2026)

3 Global Terbinafine Hydrochloride Drug Competitor Landscape by Players
3.1 Global Top Terbinafine Hydrochloride Drug Sales by Manufacturers
3.1.1 Global Terbinafine Hydrochloride Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Terbinafine Hydrochloride Drug Manufacturers by Revenue
3.2.1 Global Terbinafine Hydrochloride Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Terbinafine Hydrochloride Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Terbinafine Hydrochloride Drug Revenue in 2019
3.2.5 Global Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Terbinafine Hydrochloride Drug Price by Manufacturers
3.4 Global Terbinafine Hydrochloride Drug Manufacturing Base Distribution, Product Types
3.4.1 Terbinafine Hydrochloride Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Terbinafine Hydrochloride Drug Product Type
3.4.3 Date of International Manufacturers Enter into Terbinafine Hydrochloride Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Terbinafine Hydrochloride Drug Market Size by Type (2015-2020)
4.1.1 Global Terbinafine Hydrochloride Drug Sales by Type (2015-2020)
4.1.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2015-2020)
4.1.3 Terbinafine Hydrochloride Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Terbinafine Hydrochloride Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Type (2021-2026)
4.2.3 Terbinafine Hydrochloride Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Terbinafine Hydrochloride Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Terbinafine Hydrochloride Drug Market Size by Application (2015-2020)
5.1.1 Global Terbinafine Hydrochloride Drug Sales by Application (2015-2020)
5.1.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2015-2020)
5.1.3 Terbinafine Hydrochloride Drug Price by Application (2015-2020)
5.2 Terbinafine Hydrochloride Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Terbinafine Hydrochloride Drug Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Terbinafine Hydrochloride Drug Market Size YoY Growth 2015-2026
6.1.1 United States Terbinafine Hydrochloride Drug Sales YoY Growth 2015-2026
6.1.2 United States Terbinafine Hydrochloride Drug Revenue YoY Growth 2015-2026
6.1.3 United States Terbinafine Hydrochloride Drug Market Share in Global Market 2015-2026
6.2 United States Terbinafine Hydrochloride Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Terbinafine Hydrochloride Drug Players by Sales (2015-2020)
6.2.2 United States Top Terbinafine Hydrochloride Drug Players by Revenue (2015-2020)
6.3 United States Terbinafine Hydrochloride Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Terbinafine Hydrochloride Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Terbinafine Hydrochloride Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Terbinafine Hydrochloride Drug Price by Type (2015-2020)
6.4 United States Terbinafine Hydrochloride Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Terbinafine Hydrochloride Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Terbinafine Hydrochloride Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Terbinafine Hydrochloride Drug Price Forecast by Type (2021-2026)
6.5 United States Terbinafine Hydrochloride Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Terbinafine Hydrochloride Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Terbinafine Hydrochloride Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Terbinafine Hydrochloride Drug Price by Application (2015-2020)
6.6 United States Terbinafine Hydrochloride Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Terbinafine Hydrochloride Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Terbinafine Hydrochloride Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Terbinafine Hydrochloride Drug Price Forecast by Application (2021-2026)

7 North America
7.1 North America Terbinafine Hydrochloride Drug Market Size YoY Growth 2015-2026
7.2 North America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
7.2.1 North America Terbinafine Hydrochloride Drug Sales by Country (2015-2020)
7.2.2 North America Terbinafine Hydrochloride Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Terbinafine Hydrochloride Drug Market Size YoY Growth 2015-2026
8.2 Europe Terbinafine Hydrochloride Drug Market Facts & Figures by Country
8.2.1 Europe Terbinafine Hydrochloride Drug Sales by Country
8.2.2 Europe Terbinafine Hydrochloride Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Terbinafine Hydrochloride Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Terbinafine Hydrochloride Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Terbinafine Hydrochloride Drug Market Size YoY Growth 2015-2026
10.2 Latin America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
10.2.1 Latin America Terbinafine Hydrochloride Drug Sales by Country
10.2.2 Latin America Terbinafine Hydrochloride Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Terbinafine Hydrochloride Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Terbinafine Hydrochloride Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country
11.2.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Terbinafine Hydrochloride Drug Products Offered
12.1.5 Novartis Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Terbinafine Hydrochloride Drug Products Offered
12.2.5 GSK Recent Development
12.3 TEVA
12.3.1 TEVA Corporation Information
12.3.2 TEVA Description and Business Overview
12.3.3 TEVA Sales, Revenue and Gross Margin (2015-2020)
12.3.4 TEVA Terbinafine Hydrochloride Drug Products Offered
12.3.5 TEVA Recent Development
12.4 Dr. Reddy's Laboratories
12.4.1 Dr. Reddy's Laboratories Corporation Information
12.4.2 Dr. Reddy's Laboratories Description and Business Overview
12.4.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Products Offered
12.4.5 Dr. Reddy's Laboratories Recent Development
12.5 CIPLA LTD
12.5.1 CIPLA LTD Corporation Information
12.5.2 CIPLA LTD Description and Business Overview
12.5.3 CIPLA LTD Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Products Offered
12.5.5 CIPLA LTD Recent Development
12.6 TARO
12.6.1 TARO Corporation Information
12.6.2 TARO Description and Business Overview
12.6.3 TARO Sales, Revenue and Gross Margin (2015-2020)
12.6.4 TARO Terbinafine Hydrochloride Drug Products Offered
12.6.5 TARO Recent Development
12.7 InvaGen Pharmaceuticals
12.7.1 InvaGen Pharmaceuticals Corporation Information
12.7.2 InvaGen Pharmaceuticals Description and Business Overview
12.7.3 InvaGen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Products Offered
12.7.5 InvaGen Pharmaceuticals Recent Development
12.8 Breckenridge Pharmaceutical
12.8.1 Breckenridge Pharmaceutical Corporation Information
12.8.2 Breckenridge Pharmaceutical Description and Business Overview
12.8.3 Breckenridge Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Products Offered
12.8.5 Breckenridge Pharmaceutical Recent Development
12.9 Harris Pharmaceutical
12.9.1 Harris Pharmaceutical Corporation Information
12.9.2 Harris Pharmaceutical Description and Business Overview
12.9.3 Harris Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Products Offered
12.9.5 Harris Pharmaceutical Recent Development
12.10 Glenmark
12.10.1 Glenmark Corporation Information
12.10.2 Glenmark Description and Business Overview
12.10.3 Glenmark Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Glenmark Terbinafine Hydrochloride Drug Products Offered
12.10.5 Glenmark Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Terbinafine Hydrochloride Drug Products Offered
12.11.5 Novartis Recent Development
12.12 APOTEX
12.12.1 APOTEX Corporation Information
12.12.2 APOTEX Description and Business Overview
12.12.3 APOTEX Sales, Revenue and Gross Margin (2015-2020)
12.12.4 APOTEX Products Offered
12.12.5 APOTEX Recent Development
12.13 Jilin Wantong Group
12.13.1 Jilin Wantong Group Corporation Information
12.13.2 Jilin Wantong Group Description and Business Overview
12.13.3 Jilin Wantong Group Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Jilin Wantong Group Products Offered
12.13.5 Jilin Wantong Group Recent Development
12.14 Cussess
12.14.1 Cussess Corporation Information
12.14.2 Cussess Description and Business Overview
12.14.3 Cussess Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Cussess Products Offered
12.14.5 Cussess Recent Development
12.15 Hubei Hengan Fulin Pharm
12.15.1 Hubei Hengan Fulin Pharm Corporation Information
12.15.2 Hubei Hengan Fulin Pharm Description and Business Overview
12.15.3 Hubei Hengan Fulin Pharm Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Hubei Hengan Fulin Pharm Products Offered
12.15.5 Hubei Hengan Fulin Pharm Recent Development
12.16 Xiuzheng Pharmaceutical
12.16.1 Xiuzheng Pharmaceutical Corporation Information
12.16.2 Xiuzheng Pharmaceutical Description and Business Overview
12.16.3 Xiuzheng Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Xiuzheng Pharmaceutical Products Offered
12.16.5 Xiuzheng Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Terbinafine Hydrochloride Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Terbinafine Hydrochloride Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Companies Mentioned:

Novartis
GSK
TEVA
Dr. Reddy's Laboratories
CIPLA LTD
TARO
InvaGen Pharmaceuticals
Breckenridge Pharmaceutical
Harris Pharmaceutical
Glenmark
Orchid Healthcare
APOTEX
Jilin Wantong Group
Cussess
Hubei Hengan Fulin Pharm
Xiuzheng Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.